Long Term Outcomes After Vestibular Implantation
Launched by JOHNS HOPKINS UNIVERSITY · Jul 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a device called a vestibular implant, which may help people who experience chronic balance problems due to a condition known as bilateral vestibular hypofunction. This condition can cause issues with balance, stability, and vision, making everyday activities challenging. The trial aims to see how well this implant works for both patients who have experienced hearing loss due to medication (ototoxic cases) and those who have not. Researchers will look at improvements in balance, movement, and overall quality of life for participants who receive the vestibular implant.
To be eligible for this trial, you must be an adult over the age of 22 and have previously participated in specific research protocols at Johns Hopkins University. You should also have already received a vestibular implant. If you join the study, you can expect regular check-ups and assessments to evaluate how the implant is helping your balance and overall well-being. This trial is currently recruiting participants, and it includes individuals of all genders. If you or a loved one are facing these balance issues, this study could provide valuable insights into a potential treatment option.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Adults older than 22 years old who
- • have previously been enrolled in Johns Hopkins University Institutional Review Board protocol NA_00051349, IRB00335294 or IRB00346924 and
- • have previously been implanted with a vestibular implant under FDA IDE G150198
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
John P Carey, MD
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported